
Keywords: HDAC6 selective inhibitor; Computer-aided drug design; Anti-sepsis; HDAC; histone deacetylase; LPS; lipopolysaccharide; HDACi; histone deacetylase inhibitors; IL; interleukin; IFNγ; interferon γ; TNF-α; tumor necrosis factor-α; ZBD; zinc-binding group